Transfection of miR-218 mimics into ccRCC cells leads to a reduction in BCL9 expression at both the mRNA and protein levels, whereas transfection of miR-218 inhibitors has the opposite effect. Here, BCL9 is linked to nonpapillary renal cell carcinoma.